Sanofi's heart drugs get EMA panel nod for expanded use

Nov. 11, 2022 8:20 AM ETSanofi (SNY)By: Ravikash, SA News Editor

Night Sanofi office building in Berlin, Germany.


  • A committee of the European Medicines Agency (EMA) recommended the expanded approval of Sanofi's (NASDAQ:SNY) heart disease therapies Iscover and Plavix.
  • The active substance in Iscover is clopidogrel and in Plavix is clopidogrel hydrogen sulfate. Another heart drug from Sanofi which received the

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.